NLRP3 and lung cancer: In this study, A 549 lung cancer cells were induced with inflammation through the NLRP3 inflammasome pathways using LPS bacterial inflammation-inducing agents in combination with adenosine triphosphate (ATP), and measured cell proliferation using colony formation assay.